tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ryan Halsted, 14 are a BUY (63.64%), 8 are a HOLD (36.36%).
Analyst Ryan Halsted, currently employed at RBC, carries an average stock price target met ratio of 50.93% that have a potential upside of 8.22% achieved within 32 days.
Ryan Halsted’s has documented 44 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IQV, IQVIA Holdings.
Analyst best performing recommendations are on CRL (CHARLES RIVER LABORATORIES).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 8/6/2026. The price target of $282 was fulfilled within 5 days with a profit of $16.49 (6.21%) receiving and performance score of 12.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 19-Aug-2026
$330
$23.08 (7.52%)
$330
24 days ago
(08-Sep-2026)
1/2 (50%)
$5.31 (1.64%)
13
Buy Since 13-Aug-2025
$395
$88.08 (28.70%)
$331
1 months 21 days ago
(11-Aug-2026)
6/9 (66.67%)
$61.78 (18.54%)
102
Buy Since 12-Sep-2022
$390
$83.08 (27.07%)
$419
1 months 25 days ago
(07-Aug-2026)
4/7 (57.14%)
$70.16 (21.94%)
230
Buy Since 07-Aug-2026
$346
$39.08 (12.73%)
$400
1 months 25 days ago
(07-Aug-2026)
10/12 (83.33%)
$26.16 (8.18%)
479
Buy Since 04-Apr-2017
$430
$123.08 (40.10%)
$415
1 months 26 days ago
(06-Aug-2026)
16/19 (84.21%)
$105.62 (32.56%)
566
Which stock is Ryan Halsted most bullish on?
Which stock is Ryan Halsted most reserved on?
What Year was the first public recommendation made by Ryan Halsted?
